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ABSTRACT
Feline calicivirus is among the most common pathogenic microorganisms in upper respiratory tract disease (URTD) 
and oral lesions of cats. It leads to stomatitis, oral ulceration, ocular and nasal discharge, conjunctivitis, fever, lameness, 
anorexia, hypersalivation, pneumonia, respiratory distress, coughing, and depression in infected cats. This study aimed 
to determine the role of Feline calicivirus (FCV) in cats with the upper respiratory tract disease in the Diyarbakir region, 
Turkey, to provide treatment for infected cats and contribute to the disease prophylaxis. The study material consisted 
of 10 cats (control group) considered to be healthy according to the clinical examination and 20 cats with URTD that 
were not vaccinated against Feline calicivirus infection of different breeds, ages, and genders brought to Dicle University 
Veterinary Faculty Prof. Dr. Servet SEKIN Polyclinic with URTD. After routine clinical examinations of the animals, 
oral and conjunctival swabs and blood samples were taken. Hematological and biochemical analyzes of blood samples 
were performed. Swab samples were analyzed by the polymerase chain reaction (PCR) method for the diagnosis of 
the agent. Oral lesions, hypersalivation, ocular and nasal discharge, coughing, and breathing difficulties were seen in 
clinical examinations of cats with URTD. Feline calicivirus was detected in only one cat’s conjunctival swab sample in 
PCR analyses. As a result, we found that Feline calicivirus infection was present in cats with URTD in the Diyarbakir 
region, and 5% positivity was found in cats with clinical symptoms according to PCR analysis.
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RESUMO
O calicivírus felino está entre os microrganismos patogênicos mais comuns nas doenças do trato respiratório superior de gatos, 
determinando estomatites, ulcerações orais, descarga ocular e nasal, conjuntivite, febre, manqueira, anorexia, hipersalivação, 
pneumonia, distúrbios respiratórios, tosse e depressão. O presente trabalho foi delineado para determinar o papel do calicivírus 
felino (CVF) em gatos com doenças do trato respiratório superior na região de Diyarbakir, Turquia. Com o objetivo de orientar 
a prescrição do tratamento para os gatos infectados e contribuir com a profilaxia da doença. O material de estudo consistiu 
em 10 gatos saudáveis sem qualquer problema de saúde e 20 gatos acometidos por doenças do trato respiratório superior que 
não haviam sido vacinados contra a infecção pelo calicivírus felino. Os animais de diferentes raças, idades e gêneros foram 
encaminhados para a Universidade de Dicle, na Faculdade de Veterinária, na policlínica Professor Dr. Servet Sekin. Após o 
exame clínico de rotina dos animais, foram colhidos swabs orais e da conjuntiva e amostras de sangue. Análises hematológicas 
e bioquímicas das amostras de sangue foram realizadas e os swabs foram analisados pelo método da reação em cadeia pela 
polimerase (PCR) para diagnóstico do agente. Nos gatos infectados foram constatadas: lesões orais, hipersalivação, descargas 
oculares e nasais, tosse e dificuldade respiratória. O calicivírus felino foi detectado pela técnica de PCR no swab conjuntival 
de apenas um gato. A conclusão obtida foi que a infecção pelo calicivírus felino foi detectada pela técnica de PCR na região 
de Diyarbakir, Turquia, em gatos com doença do trato respiratório superior com a frequência de 5%.
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Introduction
The upper respiratory tract diseases (URTDs) are more 
common and the cause of deaths in animals kept in overcrowding 
* This study was summarized from the MSc thesis entitled ‘’Investigation of Feline Calicivirus Infection in Cats with Upper Respiratory System disease in 
Diyarbakir Region’’ Graduate School of Health Sciences, Dicle University. This study was presented as an oral presentation at the 3rd International Health 
Sciences Conference, 06-08 November 2019, Diyarbakir, Turkey.
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environments due to insufficient ventilation and stress. 
They are quite common in cats, and microorganisms such 
as bacteria, viruses, and fungi play a role in their etiology 
(Gourkow et al., 2013; Norsworthy, 2011).
Usually, infectious agents such as Feline Herpesvirus 
type1 (FHV-1), Feline calicivirus (FCV), Feline reovirus 
(F. reovirus), Chlamydophila felis (C. felis), Mycoplasma 
felis (M. felis), Bordetella bronchiseptica (B. bronchiseptica), 
Staphylococcus aureus (S. aureus) and β-hemolytic streptococci 
play a role in diseases of the upper respiratory tract. All 
these are associated with high morbidity and mortality, 
especially in cats that are housed together (Sykes  et  al., 
2001; Dinnage et al., 2009).
Although FCV and FHV-1 are responsible for 
about 90% of URTD in cats (Di Martino et  al., 2007; 
Edwards et al., 2008; Hawkins, 2009; Wong et al., 2013), 
FCV is reportedly more common. This high prevalence 
is due to the antigenic diversity of FCV and the inability 
of available vaccines to protect against all FCV strains 
(Gaskell et al., 2012).
FCV, which is in the Vesivirus class of the family 
Caliciviridae, can be transmitted directly by contact with oral 
and nasal discharges of patient cats or infected cats, as well 
as indirectly by contaminated cages, feeding and cleaning 
tools, and personnel (Gaskell et al., 2004; Radford et al., 
2009; Norsworthy, 2011).
The infection by calicivirus leads to stomatitis, oral 
ulceration, ocular and nasal discharge, conjunctivitis, 
pyrexia, lameness, anorexia, hypersalivation, pneumonia, 
respiratory distress, coughing, and depression in cats 
(Radford et al., 1997; Radford et al., 2009; Pereira et al., 
2018). In addition to these clinical findings, a virulent 
systemic disease (VSD) has also been reported, which 
occurs in the form of outbreaks in co-living cats, has 
a high mortality, and causes systemic febrile disease 
(Coyne et al., 2006; Battilani et al., 2013; Meli et al., 
2018).
Since anamnesis and clinical findings are not sufficient 
for the diagnosis of the disease, virus isolation, serological 
and PCR methods are used to establish a definitive diagnosis. 
PCR is the method most commonly preferred for definitive 
diagnosis because virus isolation takes time, is expensive 
and virus neutralization does not provide safe results due 
to vaccine applications (Chander et al., 2007; Radford et al., 
2009; Norsworthy, 2011; Litster, 2015).
The prognosis is considered to be good in patients other 
than cats with no anorexia and dehydration, aggressive 
treatment, and VSD-FCV-infected cats. The mortality 
rate in the VSD form of the disease is high (33% -50%) 
(Litster, 2015).
There are no antivirals approved effective against FCV 
for the treatment of the infected animals (Radford et al., 
2009; Norsworthy, 2011), but there are reports that feline 
interferon-omega and human interferon-alpha may be useful 
(Sherding, 2006; Cohn, 2011). Again, to prevent secondary 
bacterial infections, broad-spectrum antibiotic treatment 
(combinations of amoxicillin or amoxicillin-clavulanic 
acid, azithromycin, ampicillin enrofloxacin, and clavulanic 
acid/amoxicillin plus-fluoroquinolone) is recommended 
(Norsworthy, 2011; Bilal, 2013).
The treatment may be supported by cleaning the nasal 
discharge with physiological saline solution several times 
a day and applying topical ointments (Gaskell et al., 2004; 
Radford et al., 2009), giving balanced electrolyte solutions 
by intravenous (iv) or subcutaneous (sc) delivery to prevent 
the thickening of nasal and ocular secretions as a result of 
dehydration (Norsworthy, 2011), vitamin C, high-flavored, 
mixed and heated foods to encourage eating (Sherding, 
2006; Radford et al., 2007; Radford et al., 2009).
To the authors’ knowledge, no studies report the 
presence of FCV infection in cats in Diyarbakir, Turkey. 
This study aimed to determine the occurrence of FCV 
infection in cats with upper respiratory tract disease in 
the Diyarbakir region, metropolitan area of Turkey to 
reveal the status of infection in regional cats and to help 




The animal material of the study consists of 10 healthy 
cats (control group), considered healthy according to the 
clinical examination, unvaccinated, different breeds, ages, 
and genders, and 20 cats with URTD that were not vaccinated 
against Feline calicivirus infection of different breeds, ages, 
and genders brought to Dicle University Veterinary Faculty 
Prof. Dr. Servet SEKIN Polyclinic with upper respiratory 
tract disease (such as oral lesions, hypersalivation, ocular 
and nasal discharge, coughing, difficulty breathing and 
gingivitis). Samples were collected between March 2018 
and January 2019.
Dicle University Animal Experiments Ethics Committee 
decided that the permission of the Local Ethics Committee 
was not required with the letter dated February 19, 2018, 
Number 17768.
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Clinical examination and sampling
After the cat’s anamnesis was taken, routine clinical 
examinations were carried out and body temperature (T), 
heart rate (HR), and respiratory rate (R) were recorded.
Total leukocyte count (WBC), lymphocyte (Lymph), 
monocyte (Mon), granulocyte (Gran), lymph (%), Mon 
(%), Gran (%), red blood cell (RBC), hemoglobin (HGB), 
hematocrit (HCT), mean corpuscular volume (MCV), 
mean corpuscular hemoglobin (MCH) in erythrocytes, 
mean corpuscular hemoglobin concentration (MCHC), 
and platelet (PLT) values of the blood samples taken for 
hematological analysis, were detected by Mindray BC2800 
Vet Hematology Analyzer.
After the blood samples taken for biochemical analysis 
were centrifuged with the Nüve-NF800 brand device, the 
values of alanine aminotransferase (ALT) activity, blood 
urea nitrogen (BUN), and creatinine (Cre) were determined 
from the obtained serum.
Samples of oral and conjunctival swabs were taken from 
cats with upper respiratory tract disease using sterile swabs. 
The samples taken were placed in tubes containing 2 ml of 
Dulbecco’s modified eagle medium (DMEM) solution and 
delivered to Dicle University Faculty of Veterinary Medicine 
Genetic Department Laboratory under the cold chain. PCR 
was performed on the same day. The commercial vaccine 
(Felocell-CVR, Zoetis Animal Health, USA) was used as 
a positive control.
Nucleic acid extraction (RNA isolation)
Two hundred µl was taken from the sample stored 
in the DMEM solution and transferred to the PCR tube. 
200 µl also was added to the PCR tube from the mixture 
which was previously dissolved with the ’Elution Buffer’ 
and then added to the ‘Binding Buffer’. After the mixture 
was vortexed, it was then incubated for 10 min at +72 oC. 
After incubation, 100 µl of binding buffer was added to 
the mixture, and after mixing slowly, the samples were 
transferred to the filtered collection tubes and centrifuged 
for 1 min at 8000 rpm. Then, the lower collection tube 
was removed and a new tube installed, adding 500 µl 
‘Inhibitor Removal’ and again centrifuged at 8000 G for 
1 min. 450 µl of ‘Wash Buffer’ was added by removing the 
collection tube and installing a new tube and centrifuging 
for 1 min at 8000 rpm (this process was repeated twice). It 
was then centrifuged again for 10 sec at maximum speed 
(at 13,000 rpm). Finally, the filtered tubes were placed in 
1.5 ml tubes and a 50 µl ’Elution Buffer’ heated to 37 oC 
was added and centrifuged for 1 min at 8000 rpm. As a 
result of this process, viral nucleic acid was obtained using 
1.5 ml PCR tubes (High Pure Viral Nucleic Acid Kit-Roche).
cDNA synthesis
From the RNAs obtained earlier, 10 µl was taken using 
a micropipette and transferred to 0.2 ml PCR tubes. After 
1 µl Random Hexamer primer and 1 µl ddH2O were added 
onto it, it was incubated for 5 min at 65o C. After this 
incubation, 4 µl 5X Reaction Buffer, 1 µl RiboLock RNase 
inhibitor, 2 µl dNTP Mix, and 1 µl RevertAid m-muLV RT 
was added and incubated for 60 min at 42 oC, 10 min at 
45 oC, and 5 min at 70 oC, respectively.
PCR operations from cDNA
Primers to be used to detect FCV’s cDNAs were first 
diluted to be 20 pmol/µl. Then, with Tm degrees in mind, 
gradient PCR was performed at determined degrees, 
binding degrees were determined for each primer, 
and the DNAs were amplified. The 677 base pair gene 
region of the cDNA was replicated for FCV detection. 
Primers used for the detection of FCV are specified in 
Table 1 (29). First, in the PCR process, the primers used 
for the detection of FCV were amplified at different 
temperatures to determine the binding degrees. Then, 
PCR protocol was created by determining the degree of 
binding according to the brightness levels of the DNAs 
carried in the gel.
Gel electrophoresis technique
To prepare the gel running buffer, 20 ml of EDTA and 
weighed chemicals were put into a 1000 ml bottle and the 
top was completed with up to 1000 ml of distilled water. 
1X TBE was prepared by taking 200 ml from the 5X 
TBE prepared for gel preparation and running the gel in 
the tank, adding 800 ml distilled water to it. For the gel, 
1.5 g of agarose was weighed into the 100 ml 1X TBE and 
heated in the microwave until the agarose in the mixture 
dissolved. Then, 5 µl of ethidium bromide was added into 
the prepared gel and poured into the tank with combs in it, 
and waiting for 45 min for the gel to crystallize. The combs 
were removed from the frozen gel and placed in the gel 
runner tank. The inside of the tank was filled with 1X TBE 
buffer to cover the gel surface. 10 µl from the amplified DNA 
and 2 µl from the loading buffer were pipetted in a separate 
Table 1 - General FCV* primers applied for investigation in 
cats of the Diyarbakir region, Turkey, between March 
2018 and January 2019
Amplicon Primers
Size(bp) forward/reverse)
Primer 677 bp F: 5 -TTCGGCCGTTTGTCTTCC-3
R: 5 -TTGTGAATTAAAGACATCAATAGACCT-3
*FCV = Feline Calicivirus.
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place and loaded into wells in the gel to be 12 µl in total. 
A 5 µl marker was loaded into the first well to determine 
the sequencing of DNA based on their weight. The loaded 
DNAs were run in the tank at 60 amps and 110 volts for 
30-35 min. The agarose gel was removed from the tank 
and transferred to the transilluminator. The bands formed 
by DNA based on their weight were examined under UV 
light in the transilluminator.
Statistical analysis
The Student’s t-test was used to compare groups. The 
results were expressed as the mean ± standard error of the 




Clinical examination findings of cats with URTD and 
control group cats are shown in Table 2.
Laboratory Findings
The hematological examination findings of cats with 
URTD and control group cats are shown in Table 3. Serum 
biochemistry findings are shown in Table 4.
PCR Results
Only one conjunctival swab sample taken from cats with 
URTD was found positive for FCV after PCR analysis, out 
of a total of 40 oral and conjunctival swab samples. As a 
result of PCR, samples giving bands in the range of 700 bp 
and 500 bp were considered positive (Figure 1).
Discussion
FCV, which affects cats worldwide and is highly contagious, 
is among the most common pathogens of upper respiratory 
tract disease, especially in cats housed together (Radford et al., 
2001; Marsilio et al., 2005; Henzel et al., 2012).
FCV reportedly causes stomatitis, oral ulceration, ocular 
and nasal discharge, conjunctivitis, pyrexia, lameness, 
Figure 1 - Feline calicivirus investigation. Diyarbakir region, 
Turkey, between March 2018 and January 2019. Gel 
electrophoresis image of 679 bp region. M: 1500 bp 
DNA Ladder 2: Vaccine (Positive control) 3: Positive 
sample.
Table 2. Feline calicivirus investigation. Clinical examination 
findings (mean±SEM) in cats according to the group. 
Diyarbakir region, Turkey, between March 2018 and 
January 2019.
Parameters Control group (n=10)
Cats with 
URTD (n=20) P value
T (ºC) 38,17±0,10 38,32±0,18 0,18
R (/min) 43,80±2,32 28,65±1,53 0,00*
HR (/min) 137,4±6,15 122,95±4,38 0,07
T: Temparature; R: respiration rate; HR: heart rate; min: minute; *: p< 0.05
Table 3. Feline calicivirus investigation. Hematological findings 
(mean±SEM) of cats, according to the group. Diyarbakir 
region, Turkey, between March 2018 and January 2019
Parameters Control group (n=10)
Cats with 
URTD (n=20) P value
WBC (m/mm3) 18,85±3,68 25,44±3,50 0,25
Lym (m/mm3) 5,58±1,01 7,07±1,36 0,48
Mon (m/mm3) 0,71±0,13 1,26±0,74 0,25
Gra (m/mm3) 12,56±3,11 17,09±2,58 0,30
Lym (%) 32,22±4,72 27,49±2,91 0,38
Mon (%) 4,03±0,11 5,30±0,42 0,04*
Gra (%) 63,75±4,77 66,88±3,05 0,57
RBC (m/mm3) 8,94±0,97 9,76±0,69 0,50
HGB (g/dL) 14,30±1,33 14,38±1,07 0,96
HCT (%) 43,25±3,91 45,14±3,15 0,72
MCV (g/dL) 49,24±1,39 46,55±1,11 0,16
MCH (g/dL 16,16±0,39 14,63±0,34 0,01*
MCHC (g/dL) 32,93±0,23 31,66±0,30 0,01*
Plt (m/mm3) 199,2±39,42 109,9±16,20 0,02*
WBC: Total leukocyte count; Lymph: Lymphocyte; Mon: Monocyte; Gran: 
granulocyte; RBC: Red blood cell; HGB: Hemoglobin; HCT: Hematocrit; MCV: 
Mean corpuscular volume; MCH: mean corpuscular hemoglobin in erythrocytes; 
MCHC: Mean corpuscular hemoglobin concentration; PLT: Platelet.; *: p< 0.05; 
Table 4. Feline calicivirus investigation. Serum biochemistry 
findings (mean±SEM) of cats, according to the group. 
Diyarbakir region, Turkey, between March 2018 and 
January 2019
Parameters Control group (n=10)
Infected 
group (n=20) P value
BUN (mg/dL) 22,86±1,36 22,66±1,27 0,92
Cre (mg/dL) 1,24±0,14 0,88±0,08 0,02*
ALT (U/L) 67,60±15,75 85,30±11,42 0,37
BUN: Blood urea nitrogen; Cre: Creatinine; ALT: Alanine aminotransferase; 
*: p< 0.05
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anorexia, hypersalivation, pneumonia, breathing difficulties, 
coughing, and depression in cats (Radford  et  al., 2001; 
Radford et al., 2009; Tian et al., 2016; Pereira et al., 2018). 
Oral lesions, hypersalivation, ocular and nasal discharge, 
coughing, respiratory distress, and gingivitis were seen in 
cats with URTD that constitute the material of this study.
When compared with the control group, the body 
temperature of the cats with URTD was higher and the 
respiratory and heart rate were lower. It is thought that 
a higher breathing and respiration rate in control group 
cats compared to clinically diseased cats with symptoms 
compatible with FCV infection is caused by stress and 
fear because healthy animals are more sensitive to clinical 
examination.
Mon (%), MCH, MCHC, PLT, and Cre values of the 
cats with URTD were recorded as statistically significantly 
lower than the control group, but we determined that the 
results obtained were in the reference intervals reported 
for healthy cats (Turgut, 2000).
Sykes et al. (2001) reported detecting FCV infection 
in 9.6% of swab samples of cats with upper respiratory 
tract disease in Melbourne and Sydney, Australia. They 
also reported not finding FCV in any of the samples kept 
at -70 oC and that they did encounter FCV in 13.7% of the 
samples kept at +4 oC.
Helps et al. (2005) reported that in the samples taken 
and kept for analysis at -20 oC from a total of 1,748 cats 
with and without upper respiratory tract disease in 218 
different shelters in 9 different European countries, such 
as Austria, France, Germany, Italy, Netherlands, Spain, 
Sweden, Switzerland, and England, they found positivity 
of 47% and 29%, respectively.
Kang & Park (2008) found that none of the swab samples 
that were taken from the conjunctiva and oropharynx of 
78 cats and maintained at -70 oC until analysis, detected FCV.
Berger et al. (2015) reported detecting positivity in 45% 
of the oropharyngeal, nasal, and conjunctival swab samples 
they took from 200 cats with upper respiratory tract disease 
from 19 different regions of Switzerland.
Najafi  et  al. (2014) detected FCV infection in all 16 
cats (100%), none of whom had been vaccinated, showing 
clinical symptoms such as sneezing, coughing, oral ulcers, 
ocular and nasal discharge at the Small Animal Hospital 
of the University of Tehran.
Gerriets et al. (2012) reported the positivity rate of FCV 
as 30/99 by RT-PCR method in 99 cats showing clinical 
signs of upper respiratory tract infection in different parts 
of Germany.
Marsilio et al. (2005), in their study of cats with upper 
respiratory tract disease, found positivity rates in 47 oculars 
and 40 pharyngeal swab samples of 47 cats as 18 and 23, 
respectively.
Sykes et al. (2001) stated that the swab samples taken 
to determine the FCV infection are affected by the storage 
temperatures, and the positivity rate in the samples kept at 
+4 oC is higher than those kept at -20 oC and -70 oC. The 
same researchers reported that the seasons affected FCV 
infection and that the rate of infection was low in samples 
collected in late winter and early spring.
Marsilio et al. (2005) reported that the small number 
of virus particles, ribonuclease in mucosal secretions, and 
the genetic difference of FCV affect the detection of the 
virus in mucosal swabs.
In the current study, oral and conjunctival swab samples 
of 20 cats with URTD showing clinical symptoms such as 
oral lesions, hypersalivation, ocular and nasal discharge, 
coughing, breathing difficulties, and gingivitis were examined 
by PCR method. Only one sample showed positivity for 
FCV. The infection was determined in the conjunctival 
swab sample of the cat with URTD, an outdoor animal, 
6-8 months old. The current study revealed that the FCV 
infection rate was 5% in cats with URTD in our region.
We noted that this rate lower is than the rate reported 
by other researchers (Sykes et al., 2001; Marsilio et al., 2005; 
Gerriets et al., 2012; Henzel et al., 2012; Najafi et al., 2014; 
Berger  et  al., 2015; Hou  et  al., 2016). These differences 
in the prevalence of infection may be due to geographic, 
climate, and storage conditions as reported (Sykes et al., 
2001, Wang et al., 2017). Radford et al. (2007) reported 
that FCV can persist longer in colder weather conditions. 
Sykes et al. (2001) reported that FCV infections are affected 
by storage temperatures, and the positivity rate in the 
samples kept at +4o C is higher than those kept at -20 oC 
and -70 oC. The low FCV rate in this study may be because 
the swab samples were analyzed without waiting and the 
climate of the Diyarbakir region was not too cold.
The fact that the positivity detected in the conjunctival 
swab sample was not detected in the oral swab sample from 
the same animal may result from the small number of virus 
particles, presence of ribonuclease in mucosal, secretions able 
to degrade viral RNA and the genetic difference of FCV affect 
the detection of the virus in mucosal swabs, as researchers 
reported (Marsilio et al., 2005, Kang & Park, 2008).
There has been no URTD of cats, including FCV, in our 
region. Control of FCV relies on a combination of vaccination 
and management (Gaskell & Gaskell, 1997). Vaccines prepared 
from circulating strains in the region should be preferred to 
protect against FCV with vaccination (Abayli et al., 2020). 
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Cats should be housed individually unless they come from 
the same household (Radford et al., 2009).
In conclusion, 5% FCV infection was detected in cats 
with URTD in the Diyarbakir region, Turkey with the PCR 
method. We determined that 95% of cats with URTD were 
caused by other causes (fungi, bacteria, other viruses, and 
non-infectious causes). Therefore, it would be beneficial to 
research other infections to provide appropriate treatment 
and preventive measures.
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On page 4, where the Table 2 shows:
Table 2 - Feline calicivirus investigation. Clinical examination findings in cats according to the group. Diyarbakir region, Turkey, 
between March 2018 and January 2019.
Parameters Control group (n=10) Cats with URTD (n=20) P value*
T (ºC) 38,17±0,10** 38,32±0,18 0,18
R (/min) 43,80±2,32 28,65±1,53 0,00
HR (/min) 137,4±6,15 122,95±4,38 0,07
T: Temperature; R: respiration rate; HR: heart rate; min: minute. *: p< 0.05; ** (mean±SEM).
It should show:
Table 2. Feline calicivirus investigation. Clinical examination findings (mean±SEM) in cats according to the group. Diyarbakir 
region, Turkey, between March 2018 and January 2019.
Parameters Control group (n=10) Cats with URTD (n=20) P value
T (ºC) 38,17±0,10 38,32±0,18 0,18
R (/min) 43,80±2,32 28,65±1,53 0,00*
HR (/min) 137,4±6,15 122,95±4,38 0,07
T: Temparature; R: respiration rate; HR: heart rate; min: minute; *: p< 0.05
On page 4, where the Table 3 shows:
Table 3 - Feline calicivirus investigation. Hematological findings of cats, according to the group. Diyarbakir region, Turkey, between 
March 2018 and January 2019
Parameters Control group (n=10) Cats with URTD (n=20) P value*
WBC (m/mm3) 18,85±3,68** 25,44±3,50 0,25
Lym (m/mm3) 5,58±1,01 7,07±1,36 0,48
Mon (m/mm3) 0,71±0,13 1,26±0,74 0,25
Gra (m/mm3) 12,56±3,11 17,09±2,58 0,30
Lym (%) 32,22±4,72 27,49±2,91 0,38
Mon (%) 4,03±0,11 5,30±0,42 0,04
Gra (%) 63,75±4,77 66,88±3,05 0,57
RBC (m/mm3) 8,94±0,97 9,76±0,69 0,50
HGB (g/dL) 14,30±1,33 14,38±1,07 0,96
HCT (%) 43,25±3,91 45,14±3,15 0,72
MCV (g/dL) 49,24±1,39 46,55±1,11 0,16
MCH (g/dL 16,16±0,39 14,63±0,34 0,01*
MCHC (g/dL) 32,93±0,23 31,66±0,30 0,01*
Plt (m/mm3) 199,2±39,42 109,9±16,20 0,02*
WBC: White blood cell; Lymph: Lymphocyte; Mon: Monocyte; Gran: granulocyte; RBC: Red blood cell; HGB: Hemoglobin; HCT: Hematocrit; MCV: Mean 
corpuscular volume; MCH: Mean corpuscular hemoglobin in erythrocytes; MCHC: Mean corpuscular hemoglobin concentration; PLT: Platelet.
It should show:
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Table 3. Feline calicivirus investigation. Hematological findings (mean±SEM) of cats, according to the group. Diyarbakir region, 
Turkey, between March 2018 and January 2019
Parameters Control group (n=10) Cats with URTD (n=20) P value
WBC (m/mm3) 18,85±3,68 25,44±3,50 0,25
Lym (m/mm3) 5,58±1,01 7,07±1,36 0,48
Mon (m/mm3) 0,71±0,13 1,26±0,74 0,25
Gra (m/mm3) 12,56±3,11 17,09±2,58 0,30
Lym (%) 32,22±4,72 27,49±2,91 0,38
Mon (%) 4,03±0,11 5,30±0,42 0,04*
Gra (%) 63,75±4,77 66,88±3,05 0,57
RBC (m/mm3) 8,94±0,97 9,76±0,69 0,50
HGB (g/dL) 14,30±1,33 14,38±1,07 0,96
HCT (%) 43,25±3,91 45,14±3,15 0,72
MCV (g/dL) 49,24±1,39 46,55±1,11 0,16
MCH (g/dL 16,16±0,39 14,63±0,34 0,01*
MCHC (g/dL) 32,93±0,23 31,66±0,30 0,01*
Plt (m/mm3) 199,2±39,42 109,9±16,20 0,02*
WBC: Total leukocyte count; Lymph: Lymphocyte; Mon: Monocyte; Gran: granulocyte; RBC: Red blood cell; HGB: Hemoglobin; HCT: Hematocrit; MCV: 
Mean corpuscular volume; MCH: mean corpuscular hemoglobin in erythrocytes; MCHC: Mean corpuscular hemoglobin concentration; PLT: Platelet.; *: p< 0.05; 
On page 4, where the Table 4 shows:
Table 4 - Feline calicivirus investigation. Serum biochemistry findings of cats, according to the group. Diyarbakir region, Turkey, 
between March 2018 and January 2019
Parameters Control group (n=10) Cats with URTD (n=20) P value*
BUN (mg/dL) 22,86±1,36** 22,66±1,27 0,92
Cre (mg/dL) 1,24±0,14 0,88±0,08 0,02
ALT (U/L) 67,60±15,75 85,30±11,42 0,37
BUN: Blood urea nitrogen; Cre: Creatinine; ALT: Alanine aminotransferase *: p< 0.05.
It should show:
Table 4. Feline calicivirus investigation. Serum biochemistry findings (mean±SEM) of cats, according to the group. Diyarbakir 
region, Turkey, between March 2018 and January 2019
Parameters Control group (n=10) Infected group (n=20) P value
BUN (mg/dL) 22,86±1,36 22,66±1,27 0,92
Cre (mg/dL) 1,24±0,14 0,88±0,08 0,02*
ALT (U/L) 67,60±15,75 85,30±11,42 0,37
BUN: Blood urea nitrogen; Cre: Creatinine; ALT: Alanine aminotransferase; *: p< 0.05
